You just read:

Argos Therapeutics' Immunotherapy Platform Based on Recombinant Human Soluble CD83 Demonstrates Significant Promise For Solid Organ Transplantation

News provided by

Argos Therapeutics, Inc.

May 04, 2011, 08:00 ET